PET-CT Imaging Features of Meibomian Glands
1 other identifier
observational
100
1 country
1
Brief Summary
Analysis the results of Dry eye analysis results and PET-CT imaging comprehensively
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 31, 2024
CompletedFirst Submitted
Initial submission to the registry
February 27, 2024
CompletedFirst Posted
Study publicly available on registry
March 22, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedMarch 22, 2024
February 1, 2024
11 months
February 27, 2024
March 21, 2024
Conditions
Outcome Measures
Primary Outcomes (4)
Lacrimal river height
Measured by dry eye analyzer machine
Within a month of the PET imaging
Tear break-up time
Measured by dry eye analyzer machine
Within a month of the PET imaging
Tear-film lipid layer thickness
Measured by dry eye analyzer machine
Within a month of the PET imaging
Meibomian glands two-dimensional digital infrared images
Measured by dry eye analyzer machine
Within a month of the PET imaging
Eligibility Criteria
Patients who visited the ophthalmology Department of Zhongnan Hospital from January 2021 to December 2023 and had a PET-CT examination in the hospital within one month
You may qualify if:
- Patients who visited the ophthalmology Department of Zhongnan Hospital from January 2021 to December 2023 and had a PET-CT examination in the hospital within one month
You may not qualify if:
- Dry eye analysis was not performed
- History of eye surgery or trauma
- Other systemic diseases affecting the eyes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zhongnan Hospital of Wuhan University
Wuhan, Hubei, 430071, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 27, 2024
First Posted
March 22, 2024
Study Start
January 31, 2024
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
March 22, 2024
Record last verified: 2024-02